Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acamprosate Added to Escitalopram in MDD With Comorbid Alcohol Abuse/Dependence
NCT00452543Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2007
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in alcohol use disorder (AUD) and alcohol dependence comparing Escitalopram plus acamprosate with Escitalopram plus placebo (2 arms). Primary endpoints: Hamilton Rating Scale for Depression - 17 Items at 12 weeks, Total Drinking Days on the Alcohol Timeline Followback at 12 weeks and 2 more. Started Mar 2007; status: completed.
02
Drugs
acamprosate
03
Conditions
alcohol use disorder (AUD)alcohol dependence
Beyond the preview
Go deeper on NCT00452543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00452543.